Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Bassi

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Public Health|September 15, 2023
Advanced Hybrid Closed Loop users' satisfaction of telemedicine and telenursing in pediatric and young adult type 1 diabetesMarta Bassi, Francesca Dufour, Marina Francesca Strati, et al.
International Journal of Molecular Sciences|May 13, 2026
The Synthetic Cannabinoid AKB-48 Induces Cell Death in Murine Cerebellum Through Different Signaling PathwaysFabrizio De Luca, Giorgia Corli, Marta Bassi, et al.
Neuroscience and Biobehavioral Reviews|October 23, 2024
Postmortem findings of organ damage in novel psychoactive substances users: A comprehensive reviewBeatrice Benedetti, Celeste Conte, Eva Bergamin, et al.
Psychopharmacology|January 12, 2024
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidenceMarta Bassi, Sabrine Bilel, Micaela Tirri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 6, 2026
Correction to: Assessing validity and reliability of the Benefit Finding Scale in Italian people with multiple sclerosis and their caregiversRosalba Rosato, Andrea Giordano, Beatrice Biolzi, et al.
Frontiers in Medicine|June 9, 2025
Case Report: Beyond type 1 diabetes: a case of delayed MODY1 diagnosis and successful transition to sulfonylurea therapyChiara Gulisano, Concetta Aloi, Alessandro Salina, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 26, 2026
Assessing validity and reliability of the Benefit Finding Scale in Italian people with multiple sclerosis and their caregiversAndrea Giordano, Rosalba Rosato, Beatrice Biolzi, et al.
Neuropharmacology|August 18, 2024
Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterizationMarthe M Vandeputte, Sabrine Bilel, Micaela Tirri, et al.
Frontiers in Cardiovascular Medicine|July 1, 2026
4,4'-DMAR <i>in-vivo</i> acute cardiotoxicity: differences between (±)<i>cis</i>-4,4'-DMAR and its coadministration with the (±)<i>trans</i>-4,4'-DMAR isomerGiorgia Corli, Elisa Roda, Beatrice Marchetti, et al.
Frontiers in Psychology|January 13, 2018
Beyond Disease: Happiness, Goals, and Meanings among Persons with Multiple Sclerosis and Their CaregiversAntonella Delle Fave, Marta Bassi, Beatrice Allegri, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Public Health|September 15, 2023
Advanced Hybrid Closed Loop users' satisfaction of telemedicine and telenursing in pediatric and young adult type 1 diabetesMarta Bassi, Francesca Dufour, Marina Francesca Strati, et al.
International Journal of Molecular Sciences|May 13, 2026
The Synthetic Cannabinoid AKB-48 Induces Cell Death in Murine Cerebellum Through Different Signaling PathwaysFabrizio De Luca, Giorgia Corli, Marta Bassi, et al.
Neuroscience and Biobehavioral Reviews|October 23, 2024
Postmortem findings of organ damage in novel psychoactive substances users: A comprehensive reviewBeatrice Benedetti, Celeste Conte, Eva Bergamin, et al.
Psychopharmacology|January 12, 2024
Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidenceMarta Bassi, Sabrine Bilel, Micaela Tirri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 6, 2026
Correction to: Assessing validity and reliability of the Benefit Finding Scale in Italian people with multiple sclerosis and their caregiversRosalba Rosato, Andrea Giordano, Beatrice Biolzi, et al.
Frontiers in Medicine|June 9, 2025
Case Report: Beyond type 1 diabetes: a case of delayed MODY1 diagnosis and successful transition to sulfonylurea therapyChiara Gulisano, Concetta Aloi, Alessandro Salina, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 26, 2026
Assessing validity and reliability of the Benefit Finding Scale in Italian people with multiple sclerosis and their caregiversAndrea Giordano, Rosalba Rosato, Beatrice Biolzi, et al.
Neuropharmacology|August 18, 2024
Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterizationMarthe M Vandeputte, Sabrine Bilel, Micaela Tirri, et al.
Frontiers in Cardiovascular Medicine|July 1, 2026
4,4'-DMAR <i>in-vivo</i> acute cardiotoxicity: differences between (±)<i>cis</i>-4,4'-DMAR and its coadministration with the (±)<i>trans</i>-4,4'-DMAR isomerGiorgia Corli, Elisa Roda, Beatrice Marchetti, et al.
Frontiers in Psychology|January 13, 2018
Beyond Disease: Happiness, Goals, and Meanings among Persons with Multiple Sclerosis and Their CaregiversAntonella Delle Fave, Marta Bassi, Beatrice Allegri, et al.
Pageof 11